Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 46

1.

The genetic landscape of Parkinson's disease.

Lunati A, Lesage S, Brice A.

Rev Neurol (Paris). 2018 Nov;174(9):628-643. doi: 10.1016/j.neurol.2018.08.004. Epub 2018 Sep 21. Review.

PMID:
30245141
2.

New endemic familial parkinsonism in south Moravia, Czech Republic and its genetical background.

Bartoníková T, Menšíková K, Kolaříková K, Vodička R, Vrtěl R, Otruba P, Kaiserová M, Vaštík M, Mikulicová L, Ovečka J, Šáchová L, Dvorský F, Krša J, Jugas P, Godava M, Bareš M, Janout V, Hluštík P, Procházka M, Kaňovský P.

Medicine (Baltimore). 2018 Sep;97(38):e12313. doi: 10.1097/MD.0000000000012313.

3.

Association analysis of EIF4G1 and Parkinson disease in Xinjiang Uygur and Han nationality.

Ma Y, Zheng D, Li H.

Medicine (Baltimore). 2018 May;97(18):e0234. doi: 10.1097/MD.0000000000010234.

4.
5.

Genome-Scale Networks Link Neurodegenerative Disease Genes to α-Synuclein through Specific Molecular Pathways.

Khurana V, Peng J, Chung CY, Auluck PK, Fanning S, Tardiff DF, Bartels T, Koeva M, Eichhorn SW, Benyamini H, Lou Y, Nutter-Upham A, Baru V, Freyzon Y, Tuncbag N, Costanzo M, San Luis BJ, Schöndorf DC, Barrasa MI, Ehsani S, Sanjana N, Zhong Q, Gasser T, Bartel DP, Vidal M, Deleidi M, Boone C, Fraenkel E, Berger B, Lindquist S.

Cell Syst. 2017 Feb 22;4(2):157-170.e14. doi: 10.1016/j.cels.2016.12.011. Epub 2017 Jan 25.

6.

Genetic Mutation Analysis of Parkinson's Disease Patients Using Multigene Next-Generation Sequencing Panels.

Gorostidi A, Martí-Massó JF, Bergareche A, Rodríguez-Oroz MC, López de Munain A, Ruiz-Martínez J.

Mol Diagn Ther. 2016 Oct;20(5):481-91. doi: 10.1007/s40291-016-0216-1.

PMID:
27294386
7.

An updated review of Parkinson's disease genetics and clinicopathological correlations.

Ferreira M, Massano J.

Acta Neurol Scand. 2017 Mar;135(3):273-284. doi: 10.1111/ane.12616. Epub 2016 Jun 8. Review.

PMID:
27273099
8.

Commentary: Parkinson's Disease Genes VPS35 and EIF4G1 Interact Genetically and Converge on α-Synuclein.

Olszewska DA, McCarthy A, Lynch T.

Front Neurosci. 2016 Apr 18;10:162. doi: 10.3389/fnins.2016.00162. eCollection 2016. No abstract available.

9.

Other Proteins Involved in Parkinson's Disease and Related Disorders.

Cardona F, Perez-Tur J.

Curr Protein Pept Sci. 2017;18(7):765-778. doi: 10.2174/1389203717666160311122152. Review.

PMID:
26965686
10.

Eukaryotic translation initiation factor 4-γ, 1 gene mutations are rare in Parkinson's disease among Taiwanese.

Weng YC, Chen CM, Chen YC, Fung HC, Chang CW, Chang KH, Wu YR.

J Formos Med Assoc. 2016 Sep;115(9):728-33. doi: 10.1016/j.jfma.2015.07.020. Epub 2015 Oct 17.

11.

Xenopus laevis as a Model to Identify Translation Impairment.

de Broucker A, Semaille P, Cailliau K, Martoriati A, Comptdaer T, Bodart JF, Destée A, Chartier-Harlin MC.

J Vis Exp. 2015 Sep 27;(103). doi: 10.3791/52724.

12.

D620N mutation in the VPS35 gene and R1205H mutation in the EIF4G1 gene are uncommon in the Greek population.

Kalinderi K, Bostantjopoulou S, Katsarou Z, Dimikiotou M, Fidani L.

Neurosci Lett. 2015 Oct 8;606:113-6. doi: 10.1016/j.neulet.2015.08.020. Epub 2015 Aug 20.

PMID:
26300542
13.

Deregulation of protein translation control, a potential game-changing hypothesis for Parkinson's disease pathogenesis.

Taymans JM, Nkiliza A, Chartier-Harlin MC.

Trends Mol Med. 2015 Aug;21(8):466-72. doi: 10.1016/j.molmed.2015.05.004. Epub 2015 Jun 17. Review.

PMID:
26091824
14.

EIF4G1 mutations do not cause Parkinson's disease.

Nichols N, Bras JM, Hernandez DG, Jansen IE, Lesage S, Lubbe S, Singleton AB; International Parkinson's Disease Genomics Consortium.

Neurobiol Aging. 2015 Aug;36(8):2444.e1-4. doi: 10.1016/j.neurobiolaging.2015.04.017. Epub 2015 May 9.

15.

VPS35 and EIF4G1 interactions and novel candidate genes for PD: from genes to pathways and back.

Erro R.

Mov Disord. 2015 Apr;30(4):499. doi: 10.1002/mds.26187. Epub 2015 Mar 15. No abstract available.

PMID:
25771811
16.

The EIF4G1 gene and Parkinson's disease.

Deng H, Wu Y, Jankovic J.

Acta Neurol Scand. 2015 Aug;132(2):73-8. doi: 10.1111/ane.12397. Epub 2015 Mar 13. Review.

PMID:
25765080
17.

Linking the VPS35 and EIF4G1 pathways in Parkinson's disease.

Ross OA, Cook C, Petrucelli L.

Neuron. 2015 Jan 7;85(1):1-3. doi: 10.1016/j.neuron.2014.12.045.

18.

Parkinson's disease genes VPS35 and EIF4G1 interact genetically and converge on α-synuclein.

Dhungel N, Eleuteri S, Li LB, Kramer NJ, Chartron JW, Spencer B, Kosberg K, Fields JA, Stafa K, Adame A, Lashuel H, Frydman J, Shen K, Masliah E, Gitler AD.

Neuron. 2015 Jan 7;85(1):76-87. doi: 10.1016/j.neuron.2014.11.027. Epub 2014 Dec 18. Erratum in: Neuron. 2015 Feb 4;85(3):657.

19.

EIF4G1 is neither a strong nor a common risk factor for Parkinson's disease: evidence from large European cohorts.

Huttenlocher J, Krüger R, Capetian P, Lohmann K, Brockmann K, Csoti I, Klein C, Berg D, Gasser T, Bonin M, Riess O, Bauer P.

J Med Genet. 2015 Jan;52(1):37-41. doi: 10.1136/jmedgenet-2014-102570. Epub 2014 Nov 3.

PMID:
25368108
20.

Disease penetrance of late-onset parkinsonism: a meta-analysis.

Trinh J, Guella I, Farrer MJ.

JAMA Neurol. 2014 Dec;71(12):1535-9. doi: 10.1001/jamaneurol.2014.1909.

PMID:
25330418

Supplemental Content

Loading ...
Support Center